Clinical Trials Logo

Respiration Disorders clinical trials

View clinical trials related to Respiration Disorders.

Filter by:

NCT ID: NCT01540032 Not yet recruiting - Clinical trials for Aspirin Exacerbated Respiratory Disease

Low Salicylate Diet in Aspirin Exacerbated Respiratory Disease

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a low salicylate diet will improve the quality of life of patients with Aspirin Exacerbated Respiratory Disease (AERD).

NCT ID: NCT01533220 Completed - Flu Clinical Trials

Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal

Start date: January 1, 2013
Phase: Phase 3
Study type: Interventional

The common cold is a major cause of nasal obstruction and reaches children and adults two or more times a year. At the moment, there is no cure for the common cold, and therefore the reduction of symptoms is the focus of the treatment. The study has parallel distribution design, with two equal groups, in which one group will be treated by a combination of naphazoline hydrocloride + pheniramine maleate + panthenol and the other will receive treatment with naphazoline hydrocloride.

NCT ID: NCT01532180 Completed - Clinical trials for Sleep Apnea, Obstructive

Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

Start date: November 2009
Phase: N/A
Study type: Interventional

The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

NCT ID: NCT01516437 Completed - Clinical trials for Respiratory Disorders

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

Start date: February 2012
Phase: N/A
Study type: Interventional

The present study aims to assess the natural immunity to specific microbial antigens in healthy subjects and in subjects with stable COPD aged between 45-75 years.

NCT ID: NCT01505582 Completed - Low Back Pain Clinical Trials

Inspiratory Muscle Training and Low Back Pain

Start date: January 2012
Phase: N/A
Study type: Interventional

Proprioceptive weighting changes may explain differences in postural control performance. In addition, the respiratory movement has a disturbing effect on postural balance. Postural balance seems to be impaired in individuals with respiratory disorders. Besides the essential role of respiration, the diaphragm may also play an important role in the control of the trunk and postural balance. Deficits in proprioception are found in a subgroup of patients with low back pain. In addition, disorders of respiration have been identified as strongly related to low back pain. The aim of the study is to clarify whether inspiratory muscle training has a positive effect on proprioceptive postural control in individuals with recurrent low back pain.

NCT ID: NCT01505556 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease

Proprioceptive Postural Control and Diaphragm Paresis

Start date: January 2014
Phase:
Study type: Observational

Proprioceptive weighting changes may explain differences in postural control performance. In addition, the respiratory movement has a disturbing effect on postural balance. Postural balance seems to be impaired in individuals with respiratory disorders. Increased risk of falling is reported in individuals with chronic obstructive pulmonary disease. Besides the essential role of respiration, the diaphragm may also play an important role in the control of the trunk and postural balance. The aim of the study is to clarify whether proprioceptive postural control is impaired in individuals with diaphragm paresis.

NCT ID: NCT01476046 Completed - Clinical trials for Respiratory Disorders

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

Start date: March 8, 2011
Phase: Phase 1
Study type: Interventional

The main purpose of the study is to see how safe GSK1995057 is and how well it is tolerated after dosing. The study will also investigate how GSK1995057 is taken up, metabolised (chemically broken down), distributed through the body and excreted, and what some of the effects of the study drug are.

NCT ID: NCT01443845 Completed - COPD Clinical Trials

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Start date: September 2011
Phase: Phase 4
Study type: Interventional

To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination (FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very severe COPD.

NCT ID: NCT01435187 Completed - Prematurity Clinical Trials

Prematurity and Respiratory Outcomes Program (PROP)

PROP
Start date: August 2011
Phase: N/A
Study type: Observational

In survivors of extreme prematurity to 36 weeks Post Menstrual Age (PMA), specific biologic, physiologic and clinical data obtained during the initial hospitalization will predict respiratory morbidity as defined by respiratory health care utilization and respiratory symptoms, between discharge and 1 year corrected age. This protocol describes a collaboratively developed multicenter study of very preterm infants from birth through the time of discharge from the Neonatal Intensive Care Unit (NICU) and up to 1 year of age, corrected for the degree of prematurity.

NCT ID: NCT01395862 Completed - Clinical trials for Respiratory Disorders

Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

Start date: November 2007
Phase: N/A
Study type: Observational

The purpose of this study is to detect adverse drug reactions for long-term use (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients who are treated with fluticasone propionate/salmeterol xinafoate.